Legal Opinion
Endo Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.
Court of Appeals for the Federal Circuit
Decided March 28, 2019No. 2017-1240; 2017-1455; 2017-1887PublishedCited by 17 opinions
1Opinion of the Court
Stoll, Circuit Judge.
Endo Pharmaceuticals Inc. appeals the district court's decision holding the claims of U.S. Patent No. 8,808,737 ineligible under 35 U.S.C. § 101 . See Endo Pharms. Inc. v. Actavis Inc. , No. 14-cv-1381-RGA, 2015 WL 7253674 (D. Del. Nov. 17, 2015) (" District Court Op. "), adopting report and recommendation , 2015 WL 5580488 (D. Del. Sept. 23, 2015) (" Magistrate Op. "). Because the district court incorrectly concluded that the claims at issue are directed to a natural law, we reverse.
BACKGROUND
I
Endo owns the '737 patent, entitled "Method of treating pain utilizing…
2Cases cited13 opinions
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Mayo Collaborative Services v. Prometheus Laboratories, Inc.Supreme Court of the United States · 2012
- Enfish, LLC v. Microsoft CorporationCourt of Appeals for the Federal Circuit · 2016
- Berkheimer v. Hp Inc.Court of Appeals for the Federal Circuit · 2018
- Diamond v. DiehrSupreme Court of the United States · 1981
8 more not listed; retrieve them via the Exa API.
3Cited by17 opinions
- Ai Visualize, Inc. v. Nuance Communications, Inc.Court of Appeals for the Federal Circuit · 2024
- Beteiro, LLC v. Draftkings Inc.Court of Appeals for the Federal Circuit · 2024
- Illumina, Inc. v. Ariosa Diagnostics, Inc.Court of Appeals for the Federal Circuit · 2020
- Athena Diagnostics, Inc. v. Mayo Collaborative Servs., LLCCourt of Appeals for the Federal Circuit · 2019
- Beteiro, LLC v. Draftkings Inc.Court of Appeals for the Federal Circuit · 2024
12 more not listed; retrieve them via the Exa API.